STOCK TITAN
  1. Home
  2. Sec-filings
  3. MNKD
  4. [144] Mannkind Corporation SEC Filing

[144] Mannkind Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MNKD logo
Mannkind

NASDAQ:MNKD

MNKD Rankings

#3031 Ranked by Market Cap
N/A Ranked by Dividends

MNKD Latest News

Jun 9, 2025
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
May 27, 2025
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29
May 13, 2025
MannKind to Present at Upcoming Investor Conferences
May 8, 2025
MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
May 1, 2025
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

MNKD Latest SEC Filings

Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity
Jul 17, 2025
[Form 4] Mannkind Corporation Insider Trading Activity

MNKD Stock Data

1.16B
298.28M
1.66%
55.88%
9.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
DANBURY